Simple method for maintaining serum lidocaine levels in the therapeutic range

Area of Science:

• Pharmacology
• Cardiology
• Clinical Pharmacy

Background:

• Intravenous lidocaine hydrochloride is a standard treatment for ventricular arrhythmias.
• Elevated serum lidocaine levels can lead to severe toxic effects.
• Constant lidocaine infusions may result in unpredictable serum concentrations over time.

Purpose of the Study:

• To evaluate the efficacy of adjusting lidocaine infusion rates based on early serum levels.
• To determine if dosage adjustments can maintain therapeutic and non-toxic lidocaine levels.
• To prevent adverse events associated with lidocaine toxicity.

Main Methods:

• A study involving 19 patients receiving a constant lidocaine infusion.
• A second group of 32 patients had their lidocaine infusion rates adjusted based on 4-hour serum levels.
• Monitoring of serum lidocaine levels at 4 and 24 hours post-infusion initiation.

Main Results:

• Serum lidocaine levels significantly increased between 4 and 24 hours in patients with constant infusions.
• One patient in the constant infusion group experienced lidocaine toxicity.
• Dosage adjustments based on 4-hour levels prevented further increases in lidocaine levels, keeping them within the 2- to 4-mg/L therapeutic range at 24 hours.

Conclusions:

• Adjusting lidocaine infusion rates based on 4-hour serum levels is effective in maintaining therapeutic concentrations.
• This individualized dosing strategy prevents serum lidocaine levels from rising into toxic ranges.
• A simple formula can guide adjustments for prophylactic lidocaine therapy to ensure safety and efficacy.